instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal perforation'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intussusception'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver abscess'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peptostreptococcus infection'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumothorax'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,215,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Portal vein thrombosis'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 34840954 | 20,215,479 | 2021 |
What was the outcome of reaction 'Ascites'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,193,693 | 2021 |
What was the outcome of reaction 'Empyema'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Febrile neutropenia'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Fungal infection'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Gastrointestinal perforation'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
What was the outcome of reaction 'Ileal perforation'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Intestinal perforation'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Intussusception'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
What was the outcome of reaction 'Liver abscess'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Neutropenia'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,185,713 | 2021 |
What was the outcome of reaction 'Peptostreptococcus infection'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Pneumothorax'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Portal vein thrombosis'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Septic shock'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
What was the outcome of reaction 'Staphylococcal infection'? | Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the fir... | Recovering | ReactionOutcome | CC BY-NC-ND | 34840954 | 20,168,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | A rare case of Mycobacterium fortuitum infection causing chyluria.
We report a case of chyluria caused by Mycobacterium fortuitum infection in a sixty-four year old male, who was successfully treated with two weeks of amikacin, trimethoprim-sulfamethoxazole and levofloxacin followed by twenty four weeks of levofloxacin... | AMIKACIN, LEVOFLOXACIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 34840956 | 20,194,600 | 2021 |
What was the administration route of drug 'AMIKACIN'? | A rare case of Mycobacterium fortuitum infection causing chyluria.
We report a case of chyluria caused by Mycobacterium fortuitum infection in a sixty-four year old male, who was successfully treated with two weeks of amikacin, trimethoprim-sulfamethoxazole and levofloxacin followed by twenty four weeks of levofloxacin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34840956 | 20,194,600 | 2021 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | A rare case of Mycobacterium fortuitum infection causing chyluria.
We report a case of chyluria caused by Mycobacterium fortuitum infection in a sixty-four year old male, who was successfully treated with two weeks of amikacin, trimethoprim-sulfamethoxazole and levofloxacin followed by twenty four weeks of levofloxacin... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34840956 | 20,194,600 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Focal dyscognitive seizures'. | Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.
The use of steroids and other immune modulatory therapies in the treatment of severe COVID-19 pneumonia predisposes patients to the reemergence of opportunistic infections. Cytomegalovirus (CMV) reactivation can be one of them. A... | LACOSAMIDE, LEVETIRACETAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 34840957 | 20,197,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.
The use of steroids and other immune modulatory therapies in the treatment of severe COVID-19 pneumonia predisposes patients to the reemergence of opportunistic infections. Cytomegalovirus (CMV) reactivation can be one of them. A... | LACOSAMIDE, LEVETIRACETAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 34840957 | 20,197,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.
The use of steroids and other immune modulatory therapies in the treatment of severe COVID-19 pneumonia predisposes patients to the reemergence of opportunistic infections. Cytomegalovirus (CMV) reactivation can be one of them. A... | LACOSAMIDE, LEVETIRACETAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 34840957 | 20,197,773 | 2021 |
What was the administration route of drug 'MIDAZOLAM'? | Cytomegalovirus meningoencephalitis in a case of severe COVID-19 Pneumonia. A case report.
The use of steroids and other immune modulatory therapies in the treatment of severe COVID-19 pneumonia predisposes patients to the reemergence of opportunistic infections. Cytomegalovirus (CMV) reactivation can be one of them. A... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34840957 | 20,197,773 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Severe urinary retention secondary to intrathecal morphine pain pump: A case report.
Intrathecal opioid pain pumps (IPP) are sometimes prescribed for treatment of chronic nonmalignant pain. Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbid... | MORPHINE, TAMSULOSIN | DrugsGivenReaction | CC BY-NC-ND | 34840958 | 20,194,464 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary retention'. | Severe urinary retention secondary to intrathecal morphine pain pump: A case report.
Intrathecal opioid pain pumps (IPP) are sometimes prescribed for treatment of chronic nonmalignant pain. Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbid... | MORPHINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34840958 | 20,176,149 | 2022-01 |
What was the administration route of drug 'MORPHINE SULFATE'? | Severe urinary retention secondary to intrathecal morphine pain pump: A case report.
Intrathecal opioid pain pumps (IPP) are sometimes prescribed for treatment of chronic nonmalignant pain. Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbid... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34840958 | 20,176,149 | 2022-01 |
What was the administration route of drug 'MORPHINE'? | Severe urinary retention secondary to intrathecal morphine pain pump: A case report.
Intrathecal opioid pain pumps (IPP) are sometimes prescribed for treatment of chronic nonmalignant pain. Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbid... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34840958 | 20,194,464 | 2022-01 |
What was the outcome of reaction 'Urinary retention'? | Severe urinary retention secondary to intrathecal morphine pain pump: A case report.
Intrathecal opioid pain pumps (IPP) are sometimes prescribed for treatment of chronic nonmalignant pain. Severe urinary retention is not a commonly reported side effect of the IPP. In this case, an elderly female with multiple comorbid... | Recovered | ReactionOutcome | CC BY-NC-ND | 34840958 | 20,176,149 | 2022-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis.
Tofacitinib is an oral Janus kinase inhibitor. Although it contributes to the induction and maintenance of clinical remission of patients with moderate-to-severe ulcerative colitis, various malignancies have been reported after the u... | HYDROCORTISONE, INFLIXIMAB, MESALAMINE, PREDNISONE, TOFACITINIB, USTEKINUMAB, VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34840995 | 20,349,375 | 2021-11 |
What was the administration route of drug 'HYDROCORTISONE'? | Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis.
Tofacitinib is an oral Janus kinase inhibitor. Although it contributes to the induction and maintenance of clinical remission of patients with moderate-to-severe ulcerative colitis, various malignancies have been reported after the u... | Rectal | DrugAdministrationRoute | CC BY-NC-ND | 34840995 | 20,349,375 | 2021-11 |
What was the administration route of drug 'PREDNISONE'? | Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis.
Tofacitinib is an oral Janus kinase inhibitor. Although it contributes to the induction and maintenance of clinical remission of patients with moderate-to-severe ulcerative colitis, various malignancies have been reported after the u... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34840995 | 20,386,046 | 2021-11 |
What was the dosage of drug 'HYDROCORTISONE'? | Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis.
Tofacitinib is an oral Janus kinase inhibitor. Although it contributes to the induction and maintenance of clinical remission of patients with moderate-to-severe ulcerative colitis, various malignancies have been reported after the u... | UNK (ENEMA) | DrugDosageText | CC BY-NC-ND | 34840995 | 20,349,375 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast cancer metastatic'. | Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients.
Despite widespread use of repeated doses of potent bone-targeting agents (BTA) in oncology patients, relatively little is known about their in vivo effects on bone homeostasis, bone quality, and bone architecture. Traditiona... | DENOSUMAB, PAMIDRONATE DISODIUM, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34841014 | 20,705,703 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients.
Despite widespread use of repeated doses of potent bone-targeting agents (BTA) in oncology patients, relatively little is known about their in vivo effects on bone homeostasis, bone quality, and bone architecture. Traditiona... | DENOSUMAB, PAMIDRONATE DISODIUM, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34841014 | 20,705,703 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | AMIODARONE, DOMPERIDONE, ENZALUTAMIDE, PANTOPRAZOLE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 34841978 | 20,343,066 | 2021 |
What was the dosage of drug 'AMIODARONE'? | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34841978 | 20,343,066 | 2021 |
What was the dosage of drug 'DOMPERIDONE'? | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34841978 | 20,343,066 | 2021 |
What was the dosage of drug 'ENZALUTAMIDE'? | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34841978 | 20,343,066 | 2021 |
What was the dosage of drug 'PANTOPRAZOLE'? | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34841978 | 20,343,066 | 2021 |
What was the dosage of drug 'RISPERIDONE'? | Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Psychotropic medications extend corrected QT (QTc) period in the electrocardiogram (ECG). Psychiatric patie... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 34841978 | 20,343,066 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review.
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature resear... | AMIODARONE, FLECAINIDE, IVABRADINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34842781 | 20,237,278 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review.
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature resear... | AMIODARONE, FLECAINIDE, IVABRADINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34842781 | 20,237,278 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review.
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature resear... | AMIODARONE, FLECAINIDE, IVABRADINE, PROPRANOLOL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34842781 | 20,237,278 | 2021-11-23 |
What was the dosage of drug 'FLECAINIDE'? | Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review.
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature resear... | 5 MILLIGRAM/KILOGRAM, QD, ADMINISTERED AS AN OFF-LABEL COMBINATION THERAPY WITH IVABRADINE | DrugDosageText | CC BY | 34842781 | 20,237,278 | 2021-11-23 |
What was the dosage of drug 'PROPRANOLOL HYDROCHLORIDE'? | Ivabradine-Flecainide as Breakthrough Drug Combination for Congenital Junctional Ectopic Tachycardia: A Case Report and Literature Review.
Congenital junctional ectopic tachycardia (CJET) is a rare tachyarrhythmia that remains difficult to manage, with suboptimal control in most cases. Here, we report literature resear... | 4 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 34842781 | 20,237,278 | 2021-11-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | PROPOFOL, ROCURONIUM BROMIDE, ROPIVACAINE, SEVOFLURANE, SODIUM CHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | PROPOFOL, ROCURONIUM BROMIDE, ROPIVACAINE, SEVOFLURANE, SODIUM CHLORIDE, SUFENTANIL, UNSPECIFIED INGREDIENT, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34844200 | 20,258,731 | 2021-11-25 |
What was the administration route of drug 'SEVOFLURANE'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the dosage of drug 'PROPOFOL'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | CONTINUOUS | DrugDosageText | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the dosage of drug 'ROPIVACAINE'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | ROPIVACAINE 0.2% | DrugDosageText | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the dosage of drug 'VANCOMYCIN'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | VANCOMYCIN-LOADED BONE CEMENT | DrugDosageText | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the outcome of reaction 'Bone cement implantation syndrome'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Recovered | ReactionOutcome | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the outcome of reaction 'Hypoxia'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Recovered | ReactionOutcome | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the outcome of reaction 'Off label use'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Recovered | ReactionOutcome | CC BY-NC-ND | 34844200 | 20,258,731 | 2021-11-25 |
What was the outcome of reaction 'Pulmonary oedema'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Recovered | ReactionOutcome | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
What was the outcome of reaction 'Traumatic lung injury'? | Bone cement implantation syndrome induced by antibiotic-loaded bone cement covering the infected bone surface: A case report.
Bone cement implantation syndrome (BCIS) typically occurs during bone cementation and prosthesis insertion. Almost all of the models used to explain BCIS are based on studies related to hip arth... | Recovered | ReactionOutcome | CC BY-NC-ND | 34844200 | 20,295,005 | 2021-11-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hydronephrosis'. | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | ZONISAMIDE | DrugsGivenReaction | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrolithiasis'. | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | ZONISAMIDE | DrugsGivenReaction | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal disorder'. | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | LAMOTRIGINE, ZONISAMIDE | DrugsGivenReaction | CC BY | 34844581 | 20,178,465 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular acidosis'. | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | ZONISAMIDE | DrugsGivenReaction | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal vein varices'. | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | ZONISAMIDE | DrugsGivenReaction | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
What was the outcome of reaction 'Hydronephrosis'? | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | Recovered | ReactionOutcome | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
What was the outcome of reaction 'Nephrocalcinosis'? | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | Recovered | ReactionOutcome | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
What was the outcome of reaction 'Nephrolithiasis'? | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | Recovered | ReactionOutcome | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
What was the outcome of reaction 'Renal tubular acidosis'? | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | Recovered | ReactionOutcome | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
What was the outcome of reaction 'Renal vein varices'? | Symptomatic renal papillary varicosities and medullary nephrocalcinosis.
BACKGROUND
Nephrocalcinosis is often asymptomatic but can manifest with renal colic or hematuria. There is no reported association between nephrocalcinosis and renal vascular malformations, which may also be a source of hematuria. We herein presen... | Recovered | ReactionOutcome | CC BY | 34844581 | 20,197,139 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'CD4 lymphocytes decreased'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus colitis'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness neurosensory'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated mycobacterium avium complex infection'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | AMIKACIN, AZITHROMYCIN, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34844616 | 20,778,814 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level below therapeutic'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoalbuminaemia'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileal ulcer'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune reconstitution inflammatory syndrome'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphadenopathy mediastinal'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphadenopathy'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphangiectasia intestinal'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphangiectasia'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malabsorption'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nodule'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | AMIKACIN, AZITHROMYCIN, LEVOFLOXACIN | DrugsGivenReaction | CC BY | 34844616 | 20,778,814 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Protein-losing gastroenteropathy'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenomegaly'. | Protein-losing enteropathy caused by disseminated Mycobacterium avium complex infection in a patient receiving antiretroviral therapy: an autopsy case report.
BACKGROUND
Disseminated Mycobacterium avium complex infection is an important indicator of acquired immunodeficiency syndrome (AIDS) in patients with advanced hu... | ABACAVIR, AMIKACIN SULFATE, COBICISTAT, DARUNAVIR, DOLUTEGRAVIR, EMTRICITABINE, LAMIVUDINE, LEVOFLOXACIN, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 34844616 | 20,741,170 | 2021-11-29 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.